Pagsiat, Czymon Brian L.
HRN: 20-55-82 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/15/2022
AMPICILLIN 500MG (VIAL)
06/15/2022
06/21/2022
IVT
280 MG
Q8
UTI
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes